Stock D4S DAIICHI SANKYO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Daiichi Sankyo Co., Ltd. Deutsche Boerse AG

Equities

D4S

JP3475350009

Pharmaceuticals

Market Closed - Deutsche Boerse AG
Other stock markets
 02:40:03 2024-04-18 am EDT 		Pre-market 01:35:58 am
27.14 EUR -0.22% Intraday chart for Daiichi Sankyo Co., Ltd. 28.15 +3.72%
Apr. 10 Roche’s HER2-Low Metastatic Breast Cancer Diagnostic Test Secures CE Mark MT
Apr. 08 AstraZeneca's Enhertu Receives FDA Approval for HER2-Positive Solid Tumor Indication MT

Business Summary

Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows:

- sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis;

- other (0.2%): primarily real estate activities.

Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).

Number of employees: 17,435

Sales per Business

JPY in Million2022Weight2023Weight Delta
Prescription Drugs
94.3 %
977,984 93.6 % 1,205,939 94.3 % +23.31%
Health Care
5.5 %
64,703 6.2 % 70,331 5.5 % +8.70%
Others
0.2 %
2,204 0.2 % 2,207 0.2 % +0.14%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
41.7 %
558,253 53.4 % 533,508 41.7 % -4.43%
North America
31.0 %
235,997 22.6 % 396,579 31.0 % +68.04%
Europe
16.0 %
138,618 13.3 % 204,657 16.0 % +47.64%
Others
11.2 %
112,022 10.7 % 143,733 11.2 % +28.31%

Managers

Managers TitleAgeSince
Sunao Manabe CEO
 Chief Executive Officer 69 07-03-31
Hiroyuki Okuzawa PSD
 President 61 17-03-31
Ken Takeshita CTO
 Chief Tech/Sci/R&D Officer - 21-03-31
Shoji Hirashima BRD
 Director/Board Member 63 15-03-31
Masahiko Ohtsuki BRD
 Director/Board Member 64 10-03-31
Tomohiro Kodama IRC
 Investor Relations Contact - -
Akio Sakurai SAM
 Sales & Marketing - -
Takashi Fukuoka PRN
 Corporate Officer/Principal 63 13-03-31
Hideyuki Hirano PRN
 Corporate Officer/Principal - -
Hironobu Furuta PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Sawako Nohara BRD
 Director/Board Member 66 19-05-31
Kazuaki Kama BRD
 Director/Board Member 75 19-05-31
Sunao Manabe CEO
 Chief Executive Officer 69 07-03-31
Hiroyuki Okuzawa PSD
 President 61 17-03-31
Masahiko Ohtsuki BRD
 Director/Board Member 64 10-03-31
Shoji Hirashima BRD
 Director/Board Member 63 15-03-31
Yasuhiro Komatsu BRD
 Director/Board Member 66 22-05-31
Takashi Fukuoka PRN
 Corporate Officer/Principal 63 13-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,947,034,029 1,889,309,475 ( 97.04 %) 29,581,839 ( 1.519 %) 97.04 %

Shareholders

NameEquities%Valuation
Nomura Asset Management Co., Ltd.
5.190 %
101,045,800 5.190 % 3 189 M €
Nippon Life Insurance Co.
4.410 %
85,863,000 4.410 % 2 710 M €
Asset Management One Co., Ltd.
2.857 %
55,623,700 2.857 % 1 756 M €
SHIZUOKA FINANCIAL GROUP,INC.
1.562 %
30,422,000 1.562 % 960 M €
DAIICHI SANKYO CO., LTD.
1.519 %
29,580,200 1.519 % 934 M €
Mizuho Bank Pension Fund
1.285 %
25,014,130 1.285 % 790 M €
MS&AD INSURANCE GROUP HOLDINGS, INC.
0.9440 %
18,380,191 0.9440 % 580 M €
Sumitomo Mitsui Banking Pension Fund
0.7143 %
13,908,000 0.7143 % 439 M €
SUMITOMO MITSUI FINANCIAL GROUP, INC.
0.7035 %
13,697,304 0.7035 % 432 M €
TOKIO MARINE HOLDINGS, INC.
0.5031 %
9,795,627 0.5031 % 309 M €
NameEquities%Valuation
Arctic Asset Management AS (Sweden)
0.007297 %
142,069 0.007297 % 5 M €
Ramirez Asset Management, Inc.
0.003386 %
65,920 0.003386 % 2 M €
Madison Asset Management LLC
0.003374 %
65,684 0.003374 % 2 M €
Nia Impact Advisors LLC
0.001860 %
36,209 0.001860 % 1 M €
Yousif Capital Management LLC
0.001646 %
32,041 0.001646 % 1 M €
RhumbLine Advisers LP
0.001077 %
20,970 0.001077 % 664 791 €
GAMMA Investing LLC
0.000124 %
2,424 0.000124 % 76 846 €
Altair Advisers LLC
0.000045 %
876 0.000045 % 27 771 €
PNC Investments LLC
0.000007 %
137 0.000007 % 4 343 €
Wetzel Investment Advisors, Inc.
0.000004 %
83 0.000004 % 2 631 €

Holdings

NameEquities%Valuation
DAIICHI SANKYO CO., LTD.
1.52%
 29,580,200 1.52% 933,659,080 $
SHIZUOKA FINANCIAL GROUP,INC.
1.42%
 8,315,000 1.42% 79,499,216 $
ULTRAGENYX PHARMACEUTICAL INC.
1.51%
 1,243,913 1.51% 58,078,298 $
ALFRESA HOLDINGS CORPORATION
1.58%
 3,202,000 1.58% 47,021,338 $
SUMITOMO MITSUI FINANCIAL GROUP, INC.
0.04%
 569,500 0.04% 33,523,908 $
MEDIPAL HOLDINGS CORPORATION
0.99%
 2,184,007 0.99% 33,479,102 $
SUZUKEN CO., LTD.
1.23%
 952,598 1.23% 29,198,862 $
TOHO HOLDINGS CO., LTD.
1.43%
 1,091,000 1.43% 26,326,157 $
MS&AD INSURANCE GROUP HOLDINGS, INC.
0.09%
 1,435,089 0.09% 25,706,347 $
CUORIPS INC.
12.66%
 1,000,000 12.66% 24,414,420 $

Company contact information

Daiichi Sankyo Co., Ltd.

Daiichi Sankyo Head Office Bldg, A&B 3-5-1 Nihonbashi-honcho

103-8426, Tokyo

+81 3 6225 1111

http://www.daiichisankyo.co.jp
address Daiichi Sankyo Co., Ltd.(D4S)

Group companies

NameCategory and Sector
Daiichi Sankyo Europe GmbH
Logo Daiichi Sankyo Europe GmbH

Daiichi Sankyo Europe GmbH

Pharmaceuticals: MajorHealth Technology

Daiichi Sankyo Europe GmbH manufactures pharmaceutical products. The company was founded on January 22, 1910 and is headquartered in Munich, Germany.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Daiichi Sankyo Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
4,536 JPY
Average target price
5,620 JPY
Spread / Average Target
+23.90%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.97% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.58% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.85% 317B
ABBVIE INC. Stock AbbVie Inc.
+6.25% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.96% 211B
NOVARTIS AG Stock Novartis AG
-0.41% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.81% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. D4S Stock
  5. Company Daiichi Sankyo Co., Ltd.